These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 1277728

  • 1. The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease.
    Branch RA, James JA, Read AE.
    Clin Pharmacol Ther; 1976 Jul; 20(1):81-9. PubMed ID: 1277728
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
    Wood AJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG.
    Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957
    [Abstract] [Full Text] [Related]

  • 10. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
    Breimer DD, Zilly W, Richter E.
    Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW, Penhall RK, Priestly BG, Frewin DB, Phillips PJ, Clarkson AR.
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic oral cimetidine on apparent liver blood flow and hepatic microsomal enzyme activity in man.
    Daneshmend TK, Ene MD, Parker G, Roberts CJ.
    Gut; 1984 Feb; 25(2):125-8. PubMed ID: 6693040
    [Abstract] [Full Text] [Related]

  • 17. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
    Relling MV, Crom WR, Pieper JA, Cupit GC, Rivera GK, Evans WE.
    Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
    [Abstract] [Full Text] [Related]

  • 18. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.
    Homeida M, Roberts CJ, Halliwell M, Read AE, Branch RA.
    Gut; 1979 Jul; 20(7):596-601. PubMed ID: 488757
    [Abstract] [Full Text] [Related]

  • 19. Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects.
    Andersen V, Sonne J, Larsen S.
    Scand J Gastroenterol; 1999 Aug; 34(8):813-7. PubMed ID: 10499483
    [Abstract] [Full Text] [Related]

  • 20. A randomized prospective controlled study of the metabolism and hepatotoxicity of halothane in humans.
    Cousins MJ, Gourlay GK, Knights KM, Hall PD, Lunam CA, O'Brien P.
    Anesth Analg; 1987 Apr; 66(4):299-308. PubMed ID: 3565792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.